{"id":"W2042846576","doi":"10.1097/jto.0b013e318168c815","title":"Second-Line Treatment of Advanced Non-small Cell Lung Cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Docetaxel; Pemetrexed; Erlotinib; Gefitinib; Chemotherapy; Oncology; Lung cancer; Internal medicine; Performance status; Cancer; Intensive care medicine; Epidermal growth factor receptor; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003193184,0.0003980981,0.00164675,0.0006775219,0.0006391366,0.0006912081,0.000572951,0.0008473877,0.008170187],"category_scores_gemma":[0.0003886963,0.0001125931,0.001161039,0.0004827678,0.0001386119,0.0004340978,0.0003048315,0.001231241,0.001408688],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006672251,"about_ca_system_score_gemma":0.0004228185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009480828,"about_ca_topic_score_gemma":0.005327438,"domain_scores_codex":[0.9997863,0.00003453225,0.00001213318,0.00004720116,0.00004560548,0.00007411959],"domain_scores_gemma":[0.9997502,0.00004534285,0.00004159367,0.00001967149,0.00003219859,0.0001110727],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01640548,0.005866877,0.1142203,0.00238275,0.001893938,0.008649416,0.0003279434,0.002356221,0.06435033,0.001535551,0.05247375,0.7295375],"study_design_scores_gemma":[0.01075607,0.04880107,0.5900677,0.0008927791,0.00231994,0.04663068,0.0006562287,0.005127283,0.04761345,0.002201428,0.2447733,0.0001600965],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8833291,0.06201148,0.002228291,0.004489456,0.002161332,0.0006652222,0.003966819,0.0004226406,0.04072568],"genre_scores_gemma":[0.9634261,0.01068833,0.00125108,0.002818579,0.0007169221,0.0002588222,0.00541211,0.00007228875,0.01535579],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008170187,"threshold_uncertainty_score":0.02733201,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02478428704914597,"score_gpt":0.4360008639625567,"score_spread":0.4112165769134107,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}